罗格列酮对2型糖尿病患者的血糖、高胰岛素血症及尿白蛋白排泄的影响

下载PDF

导出

作者康伟王肃闫复兴

机构地区天津市塘沽医院内分泌科

出处《海南医学》 CAS 2005年第9期73-73,共1页 Hainan Medical Journal

关键词 2型糖尿病患者高胰岛素血症尿白蛋白排泄高血糖罗格列酮胰岛素抵抗终末器官损伤微量蛋白尿终末期肾病

参考文献7

1Valmadrid CT et al. The risk of cardiovascular disease mortality associated with microal buminuria and gross proteinuria in persons with older-onset aliabetes mellitus. Arch Intern Med 2000,160:1093-1100.
2De Fronzo RA: The triumvirate: beta cell, muscle,and liver. A collusion responaible for diabetees. Diabetes 1988,37:667-687.
3De Fronso RA: Pathogenesis of type Ⅱ (non-insulin dependent) diabetes mellitus: a balanced overview.Diabetologia 1992,35:389-397.
4Roman SH, Harria MI: Management of diabetes mellitus from a public health perspective: current therapies for diabetes. Endocrinol Metab Clin N Am 1997,26:443-473.
5Saltiel AR, Horikoshi H:Thiaazolidinedionea are novel insulinsensitizing agents Curr Opin Endocrinol Diabetes 1995,2:341-347.
6Aarulkar AA, Pendergrass MI, Granda-Ayala R, etal. Nonhypoglycemic effects of thiazolidinedionea.Ann Intern Med 2001,134:61-71.
7Arioglu E, Dumcan-Morin J, Sebring N, et al. Efficacy and safety of troglitazone in the treatment of lipodystropht syndromes Ann Intem Med 2000,133:263-274.

海南医学

2005年第9期

内容加载中请稍等...